10 unchanged sentences
See Note 10, Debt , to our consolidated financial statements included herein for further discussion of our 2025 Notes, which bears interest at a fixed rate.
−Removed: At December 31, 2023, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6 million of principal remains outstanding on the Flexion 2024 Notes.
−Removed: As a result of the Flexion Acquisition and as discussed in more detail in Note 11, Debt , to our consolidated financial statements included herein, any future conversion rights for the Flexion 2024 Notes are subject to the occurrence of any future events giving rise to such conversion rights under the indenture governing the Flexion 2024 Notes.
+Added: At December 31, 2024, $202.5 million of principal remains outstanding on the 2025 Notes.
+Added: The fair value of our 2029 Notes is impacted by both the fair value of our common stock and interest rate fluctuations.
+Added: As of December 31, 2024, the estimated fair value of the 2029 Notes was $861 per $1,000 principal amount.
+Added: See Note 10, Debt , to our consolidated financial statements included herein for further discussion of our 2029 Notes, which bears interest at a fixed rate.
+Added: At December 31, 2024, all $287.5 million of principal remains outstanding on the 2029 Notes.
The TLA Term Loan provides for a single-advance term loan in the principal amount of $150.0 million and is scheduled to mature on March 31, 2028.
2 unchanged sentences
As of December 31, 2024, borrowings under the TLA Term Loan consisted entirely of term benchmark borrowings at a rate of 7.43%.
−Removed: Pacira BioSciences, Inc.
−Removed: | 2023 Form 10-K | Page 84
−Removed: Table of Content s
−Removed: hypothetical 100 basis point increase in interest rates would increase interest expense over the next 12 months by approximately $1.2 million, based on the balances outstanding for these borrowings as of December 31, 2023.
+Added: A hypothetical 100 basis point increase in interest rates would increase interest expense over the next 12 months by approximately $1.1 million, based on the balances outstanding for these borrowings as of December 31, 2024.
We have agreements with certain vendors and partners that operate in foreign jurisdictions.
3 unchanged sentences
In the event of non-performance or non-payment, there may be a material adverse impact on our financial condition, results of operations or net cash flow.
+Added: Pacira BioSciences, Inc.
+Added: | 2024 Annual Report on Form 10-K | Page 86
Financial Statements and Supplementary Data
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.